Pharmaceuticals · RANCHO CUCAMONGA, CA, United States
$19.02
+0.96% (+$0.18)2026-07-09
Smart-Money SignalNeutral · 48/100— Insiders are net sellers over 90 days (-$14K, 1 sale vs 3 buys)
Revenue$170.5M
Net Income$25.3M
EPS$0.51
Gross Margin50.0%
Market Cap$896.6M
Price Performance
Historical data including institutional events
Company Profile
M
Mary Z. Luo
CEO & Executive Director
Amphastar Pharmaceuticals is a publicly traded American speciality pharmaceutical company. It was incorporated in May 2004 and primarily develops, manufactures, and sells inhalation and intranasal products.
